BioPharmX down 15% after hours on stock sales agreement

|About: BioPharmX Corporation (BPMX)|By:, SA News Editor

BioPharmX (NYSEMKT:BPMX) slumps 15% after hours in response to its agreement with Jones Trading for the at-the-market sale of up to $8.5M of its common stock. Jones will earn a 3% commission for its efforts.

Subscribe for full text news in your inbox